Blog

Is It Too Late to Buy Amazon Stock?

One can understand the sentiment that investors have missed out on Amazon (NASDAQ: AMZN). After a massive sell-off in 2022, the stock has risen by over 60% this year. Moreover, investors reacted

TheMotleyFool

0

Paying Your Student Loans Could Help Your Retirement Readiness in 2024 Thanks to This Policy

401(k) matches have been one of the main job perks employers have used to entice new hires for years, but for a lot of young workers, they're not all that attractive. Many recent grads have

TheMotleyFool

0

3 Reasons to Buy SoFi Stock Right Now

Earnings season is shaping up to be better than expected for a lot of companies. That's changing the image of how the economy is doing while inflation still is elevated and interest rates remain

TheMotleyFool

0

Down More Than 90% From the Highs, This Ridiculously Cheap Stock Could Be Worth a Closer Look

There is no argument that insurance disruptor Lemonade (NYSE: LMND) has products that resonate with customers. Thanks to its user-friendly application and claims processes, the company has grown its

TheMotleyFool

0

Better Stock Buy: Realty Income vs. Dollar General

Shares of retailer Dollar General (NYSE: DG) and retail-focused real estate investment trust (REIT) Realty Income (NYSE: O) are both down materially over the past year. However, there's a big

TheMotleyFool

0

Palantir Is Quietly Emerging as a Leader in Artificial Intelligence (AI)

One of the most watched companies on Wall Street is Palantir (NYSE: PLTR). The data analytics company was founded 20 years ago by Silicon Valley entrepreneur Peter Thiel. For many years

TheMotleyFool

0

Is Microsoft Stock a Buy?

If you've been waiting for the right time to buy Microsoft (NASDAQ: MSFT) stock, this could be your chance. A recent pullback in the tech sector has pushed shares off their 2023 highs even as the

TheMotleyFool

0

Got $5,000? 3 Tech Stocks to Buy and Hold for the Long Term

Let's say you came into $5,000. How would you spend it? A vacation? A top-of-the-line 77-inch OLED television? Perhaps some jewelry?

Of course, as rewarding as each of those purchases might be, it's

TheMotleyFool

0

Ozempic Sales Soar 56% in Q3. But Is Eli Lilly a Better Stock to Buy Than Novo Nordisk?

Is the fervor over Ozempic just a passing fad? It doesn't appear to be the case after Novo Nordisk (NYSE: NVO) announced its results for the first nine months of 2023 on Thursday morning.

Ozempic

TheMotleyFool

0

Charlie Munger Just Singled Out These 5 Warren Buffett Stocks as "No-Brainer" Picks

Famed stock-picker Charlie Munger is 99 years old and still going strong. The Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) vice chairman remains an astute investor, along with his business partner

TheMotleyFool

0

Billionaires Bill Gross, Steve Cohen, and Leon Cooperman Predict a Recession Is Coming. Here's What Investors Should Do If They're Right.

What's in store for the U.S. economy and the stock market? No one knows for sure. However, that doesn't prevent people from expressing their opinions.

Some economists believe that the U.S. will be

TheMotleyFool

0

Where Will Costco Stock Be in 3 Years?

Costco (NASDAQ: COST) isn't your typical retailer -- it is actually a club, with membership fees. This fact changes the entire equation as you look at the stock. That is why, in three years time

TheMotleyFool

0

Don't Believe Everything You Read. This Ultra-High Dividend Yield Is as Good as Gone.

Investors looking at stocks with huge yields need to hit the pause button because sometimes the dividend yields aren't what they seem. That's the case today with Hawaiian Electric Industries (NYSE:

TheMotleyFool

0

Altria Stock: Buy, Sell, or Hold?

Altria (NYSE: MO) sells Marlboro cigarettes in the United States. It's an incredibly strong brand with a market share of 42.3% in the premium category. But that's about all the good news that Altria

TheMotleyFool

0

CVS Health Is Down 27% This Year. Is the Stock a Buy on the Dip?

Shares of CVS Health (NYSE: CVS) have tumbled about 27% in 2023. At its beaten-down price, the stock offers an above-average dividend yield, and it has a track record of raising its payout rapidly.

TheMotleyFool

0

Is AbbVie Stock a Buy Now?

With its diluted earnings per share (EPS) collapsing by nearly 55% in the third quarter to reach $1, it's easy to see why now might not seem like a good time to buy AbbVie (NYSE: ABBV) stock. To

TheMotleyFool

0